Partitioning of Chemotherapeutics into Nuclear Condensates—Opening the Door to New Approaches for Drug Development

Klein et al. (2020) demonstrate for the first time that small-molecule cancer therapeutics are selectively partitioned and concentrated within phase-separated nuclear condensates, providing new insights to drug efficacy and creating the opportunity for enhanced control of therapeutic targeting.